Count on Worldwide to Deliver a Successful Autism Study

According to a 2014 estimate by the Centers for Disease Control, more than 1 in 60 children are affected by autism spectrum disorder (ASD). Only 14 years earlier, the incidence rate was just 1 in 150, so its prevalence is increasing at a very rapid rate. Many researchers are trying to shed light on the causes of the disorder (which are still not fully understood), while others are searching for therapeutic interventions that can mitigate both the physical and emotional challenges that often accompany the presentation of ASD.

The breadth of these emotional behaviors and the variety of physical challenges associated with ASD create challenges for researchers. If you are testing a new ASD therapy, how do you define your candidate pool? How do you source participants that map to your pool, and where do you find both clinicians and facilities who have the background and experience to provide you with the skills and understanding you need to run your trial? You expect your trials to produce clean, consolidated data that can help inform your next step, but how will you capture, consolidate, validate, and cleanse that data?

You can count on Worldwide Clinical Trials to help you through each of these challenges. With more than 30+ years of experience in supporting research and clinical trials in the area of CNS disorders, Worldwide is an internationally acclaimed expert in the area of clinical trial management. We offer full-service Phase IPhase IV trial support, as well as worldwide access to clinicians and facilities trained to conduct ASD trials. Worldwide can also manage and monitor your trial’s dataflow using a worldwide infrastructure purpose-built to streamline the acquisition, consolidation, and cleansing of clinical trial data. You can rely on Worldwide to ensure that your trial provides you with the data and the insights you need to take the next step with confidence.